siRNA capable of restraining hsa_circ_0027477 expression and application of siRNA
A nucleotide and sequence technology, applied in the field of medical material technology and medicine, can solve problems such as changes in cell regulation programs and physiological consequences, and achieve good inhibitory effect, small side effects, and long modification half-life
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment
[0011] The silent RNA sequences in this example are: CAUACAUACAGGACCCUGA (SEQ ID NO.2) and CAUACAGGACCCUGAUGCU (SEQ ID NO.3) and complementary sequences, all sequences are from the 5-end to the 3-end, and all sequences are added at the end dTdT. The RNA sequence information of hsa_circ_0027477 exists in the UCSC database. This research is supported by Yunnan Provincial Science and Technology Plan Project - General Project (2017FB123). .
[0012] control synthesis
[0013] First, nucleotides were synthesized by Shanghai Gemma Pharmaceutical Technology Co., Ltd., and a double-stranded RNA sequence containing its complementary sequence was synthesized. The negative control siRNA sequence No. A06001 of Gemma Pharmaceutical Technology Co., Ltd. was used as the negative control of the control group.
[0014] Cell culture: A549 or XWLC-05 cells were cultured in 1640 culture base containing 10% fetal bovine serum at 37°C and 5% CO2. Spread 2500 cells per well in a 96-well plate. ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More